Filing Details
- Accession Number:
- 0001127602-25-014460
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-15 16:25:39
- Reporting Period:
- 2025-05-14
- Filing Date:
- 2025-05-15
- Accepted Time:
- 2025-05-15 16:25:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1663408 | W. John Kapples | C/O Insulet Corporation 100 Nagog Park Acton MA 01720 | Svp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-05-14 | 5,278 | $95.43 | 28,458 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-05-14 | 5,278 | $318.47 | 23,180 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2025-05-14 | 5,278 | $0.00 | 5,278 | $95.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2029-04-01 | No | 4 | M | Direct |
Footnotes
- The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $318.09 to $319.17. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option, which is fully vested, vested over a four-year period with 25% of the total award vesting on each of the first, second, third and fourth anniversaries of the grant date.